Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.7 (
adenine phosphoribosyltransferase
)
692
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Evidence for a two-step model to explain the high-frequency expression of the recessive phenotype at the autosomal
adenine phosphoribosyltransferase
(
APRT
;
EC 2.4.2.7
) locus in Chinese hamster ovary (CHO) cells was given by Simon et al. [Simon, A. E., Taylor, M. W., Bradley, W. E. C. & Thompson, L. (1982) Mol. Cell. Biol. 2, 1126-1133]. This model proposed a high-frequency event, leading to allelic inactivation or a loss of gene function, and a low-frequency event, causing a structural alteration of the
APRT
protein. Either event could occur first, resulting in two classes of heterozygotes. We have analyzed the low-frequency event that gave rise to the class 2 aprt heterozygote D416 and the high-frequency event that led to
APRT
- cells derived from D416. Genomic Southern blots of
Msp
I- or Hpa II-digested DNA from wild-type CHO, aprt heterozygote D416, and two
APRT
- cell lines derived from D416 indicate a loss of a specific
Msp
I/Hpa II recognition sequence at one aprt locus in the heterozygote that correlates with the production of the electrophoretically altered
APRT
protein found in D416. The
APRT
- mutants are homozygous for the loss of this
Msp
I/Hpa II site. By using an additional CHO gene as an internal control, it was determined that the
APRT
- mutants contain only a single copy of the altered aprt gene. Thus, the high-frequency event that produces
APRT
- mutants derived from D416 is not an inactivation event but rather a deletion of the wild-type aprt gene.
...
PMID:High-frequency mutation at the adenine phosphoribosyltransferase locus in Chinese hamster ovary cells due to deletion of the gene. 657 71